Drug Database
AN

anti-D immunoglobulin

✓ Approved

Kedrion · Polyclonal Antibodies · Polyclonal Antibodies

What is anti-D immunoglobulin?

anti-D immunoglobulin is a polyclonal antibodies developed by Kedrion. It is approved for therapeutic indications via injectable (others) or intramuscular (im) injection.

Drug Profile

CompanyKedrion
Drug ClassPolyclonal Antibodies, Cell-based Therapies, Antibody
RouteInjectable (Others), Intramuscular (IM) Injection
StatusApproved

Therapeutic Indications

anti-D immunoglobulin is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Congenital, familial and genetic disordersRhesus haemolytic disease of newborn✓ Approved

Related Research Articles

PubMedJournal of microbiology and biotechnology2026-10-22

Live and Heat-Killed Lactiplantibacillus plantarum HY7715 Attenuate D-Galactose-Induced Aging-Related Brain Changes and Blood-Brain Barrier Disruption with Gut Microbiota Modulation in Mice.

Baik Jimin J, Gwon Hyeonjun H, Kim Joo-Yun JY, Shim Jae-Jung JJ et al.

Aging is associated with changes in systemic homeostasis, intestinal barrier integrity, and brain function. This study investigated the effects of Lactiplantibacillus plantarum HY7715 on aging-related alterations in a D-galactose-induced accelerated aging mouse model. Male C57BL/6J mice were administered D-galactose for 8 weeks and orally treated with live or heat-killed HY7715. D-galactose increased circulating advanced glycation end products (AGEs), blood-brain barrier (BBB) permeability, hippocampal inflammation, and aging-related molecular changes, while impairing cortical and colonic tight junction-associated markers. Both live and heat-killed HY7715 reduced serum AGE levels, Evans blue leakage, and hippocampal inflammatory responses, while restoring CLDN5 immunoreactivity, tight junction-associated gene expression, and antioxidant-related gene expression. HY7715 also attenuated senescence- and apoptosis-related changes in the hippocampus and colonic tight junction- and inflammation-related gene expression changes. Gut microbiota analysis showed taxon-specific changes following HY7715 treatment, including significant increases in Bifidobacterium in both HY7715-treated groups, whereas live HY7715 was associated with significant changes in microbial community structure. Several microbial taxa were correlated with serum AGEs, BBB permeability, and neuroinflammation-related parameters. Together, these results show that both live and heat-killed HY7715 attenuated multiple aging-related changes in the D-galactose-induced accelerated aging model, accompanied by changes in gut microbiota composition.

PubMedJournal of clinical laboratory analysis2026-10-22

The Impact of Immunoglobulins on Cardiovascular Diseases and Lipid Profiles in Elderly and Middle-Aged Chinese Individuals: A 15-Year Retrospective Study.

Li Ya Y, Jiao Li L, Gao Yuan Y, Ni Xue-Feng XF

Humoral immunity defends via immunoglobulins. This study aimed to evaluate the association between immunoglobulins and CVDs and lipid profiles in a cohort of individuals aged 45 years and older. Data from 982 subjects were analyzed. The cohort had a median age of 61 years (IQR 56-72), was predominantly male (84.8%), and had a high prevalence of CVDs at baseline, including hypertension (30.3%), dyslipidemia (20.7%), arrhythmia (22.3%), coronary heart disease (12.1%), and atrial fibrillation (4.5%). Logistic regression analysis was used to examine the association between baseline and time-varying serum levels of IgG, IgA, and IgM and the presence of five CVDs: coronary heart disease, atrial fibrillation, arrhythmia, hypertension, and dyslipidemia. We additionally explored the relationship between these immunoglobulin levels and lipid profiles. No significant differences in immunoglobulin levels were found between CVD and non-CVD groups at baseline, and baseline immunoglobulin levels were not associated with any CVD. However, longitudinal changes in IgG and IgA levels were positively associated with changes in free fatty acids (FFAs). Intriguingly, longitudinal increases in IgM levels were positively associated with total cholesterol, LDL-C, non-HDL-C, and HDL-C. This study provides longitudinal evidence that increases in IgG and IgA levels are associated with elevated FFA levels, while increases in IgM are associated with an adverse lipid profile characterized by higher total cholesterol, LDL-C, and non-HDL-C, and lower HDL-C. These findings suggest a link between humoral immunity and lipid metabolism that warrants further investigation, with potential implications for cardiovascular risk assessment.

PubMedFrontiers in immunology2026-10-22

Case Report: Acute liver failure in systemic lupus erythematosus with autoimmune hepatitis-primary biliary cholangitis overlap: a belimumab-containing regimen and longitudinal follow-up.

Zhang Lina L, Zhang Tong T, Zhang Jing J, Wang Xiuhong X et al.

Severe autoimmune liver injury as the first manifestation of systemic lupus erythematosus (SLE) is rare, and concomitant autoimmune hepatitis-primary biliary cholangitis (AIH-PBC) overlap is uncommon. B-cell-activating factor (BAFF) provides a biological rationale for adjunctive therapy, although clinical evidence remains limited. A 72-year-old woman presented with 4 weeks of fatigue and anorexia and developed coagulopathy (international normalized ratio [INR] 1.8), ascites, and hepatic encephalopathy. Autoimmune testing showed antinuclear antibody 1:1280, high-titer anti-double-stranded DNA antibodies with hypocomplementemia, immunoglobulin G (IgG) 30.0 g/L, and antimitochondrial antibody positivity. Hepatitis B surface antigen, hepatitis C antibody, hepatitis E antibody, and Epstein-Barr virus and cytomegalovirus DNA tests were negative. Liver biopsy 42 days after corticosteroid initiation demonstrated interface hepatitis, destructive small-bile-duct injury, plasma cell-rich inflammation, and Batts-Ludwig stage 2 fibrosis without cirrhosis, supporting a clinicopathologic diagnosis of AIH-PBC overlap. Previously unrecognized chronic autoimmune liver disease could not be excluded. Prednisolone was started at 50 mg/day, followed 10 days later by intravenous belimumab, with concomitant ursodeoxycholic acid. Tacrolimus was added during maintenance. By 10 October 2025, liver biochemistry had improved, IgG was 9.42 g/L, and prednisolone had been reduced to 2.5 mg/day. Liver stiffness decreased from 21.5 to 9.7 kPa. Sustained biochemical improvement occurred during a belimumab-containing multidrug regimen. This observation does not establish the independent efficacy of belimumab or histological regression of fibrosis.

PubMedThe Journal of the Association of Physicians of India2026-10-22

Beyond Fever-The Changing Face of Acute Leptospirosis: A Retrospective Observational Study from Western India.

Agarwal Arun A, Choudhary Sachin S, Agarwal Aakanksha A, Raval Hetashree H et al.

Leptospirosis is a zoonotic infection caused by pathogenic Leptospira species and remains a significant cause of acute febrile illness in tropical regions. Its clinical spectrum ranges from mild, self-limiting illness to severe multi-organ dysfunction. The disease is broadly classified into anicteric and icteric (Weil's disease) forms, the latter associated with jaundice and increased morbidity. In India, diagnosis is often challenging due to overlapping features with other endemic infections such as dengue and scrub typhus. Coinfections and changing epidemiological patterns, including increasing urban cases, further complicate clinical assessment. This study evaluated the demographic profile, clinical characteristics, organ involvement, coinfections, severity, management, and outcomes of adults hospitalized with acute leptospirosis, with comparison between icteric and anicteric phenotypes. This retrospective observational study included 78 adults with laboratory-confirmed acute leptospirosis admitted over 30 months to a tertiary care hospital in Rajasthan, India. Diagnosis was established by positive Leptospira-specific immunoglobulin M (IgM) serology (>11 NTU) and/or polymerase chain reaction (PCR). Data regarding demographics, comorbidities, clinical features, organ involvement, coinfections, treatment, and outcomes were extracted from medical records. Organ involvement was defined using predefined clinical and laboratory criteria across major systems. Severe disease was defined as dysfunction of two or more organ systems. Icteric leptospirosis was defined by clinical jaundice and/or serum bilirubin ≥3 mg/dL. Coinfections were confirmed through appropriate laboratory testing. Continuous variables were expressed as median (interquartile range) and categorical variables as frequency (%). Subgroup comparisons were performed using the Mann-Whitney U test and Fisher's exact test. The median age was 57 years (interquartile range 41-68), with slight male predominance (52.6%). Although 59% of patients were from rural areas, 41% were urban residents. Hypertension (25.6%) and diabetes mellitus (29.5%) were common comorbidities, while 42.3% had no prior illnesses. Anicteric disease predominated (84.6%), and 15.4% had icteric leptospirosis. Fever was present in 93.6% of patients. Hepatic (69.2%) and respiratory (66.7%) involvement were most frequent, and multi-organ dysfunction occurred in 61.5%. Coinfections were identified in 52.6% of cases, most commonly dengue (17.9%) and scrub typhus (14.1%). Coinfected patients were younger and had fewer comorbidities, with lower rates of renal, respiratory, and neurological involvement and reduced need for ventilatory support. Icteric patients were significantly younger (median 31.5 vs 58 years) and had longer hospital stays (10.5 vs 7 days). Hepatic involvement was universal in the icteric group, and secondary hemophagocytic lymphohistiocytosis (HLH) was markedly more frequent. Mortality was higher among icteric patients but did not reach statistical significance. Mechanical ventilation was required in 10.3% of patients. The median hospital stay was 7 days, and overall mortality was 2.6%, with both deaths occurring in patients with severe multi-organ dysfunction. Acute leptospirosis exhibits diverse clinical presentations with frequent multi-organ involvement in hospitalized adults. Coinfections are common but did not consistently worsen outcomes. Icteric disease represents a more severe phenotype associated with greater complications and prolonged hospitalization. Early diagnosis and timely supportive management are critical to achieving favorable outcomes in endemic settings.

PubMedChemical Society reviews2026-10-22

Recent applications of asymmetric hydrogenation in total synthesis of natural products and drugs.

Li Dong D, Lu Jingya J, Zhang Yao Y, Duan Ya-Nan YN et al.

Natural products with unique structures and promising bioactivities are vital for drug discovery. The efficient and concise synthesis of these natural products and analogues thus becomes even more critical for further drug screening. Over the past several decades, asymmetric hydrogenation has witnessed remarkable progress and evolved into a powerful and versatile strategy for the construction of chiral molecules. Starting from readily available building blocks, the enantioselective asymmetric hydrogenation of unsaturated bonds offers a straightforward strategy for the rapid construction of isolated or contiguous stereogenic centers at both early and late stages. In this review, we present a comprehensive overview of asymmetric hydrogenation of diverse unsaturated bonds, categorized by structural types. In particular, we highlight the application of asymmetric hydrogenation strategies in the total synthesis of natural products and drugs.

PubMedNatural product reports2026-10-22

Natural products shape microbial ecology and disease in the cystic fibrosis airway.

Bhowmik Niladri N, Stubbendieck Reed M RM

Covering up to 2026Cystic fibrosis (CF) is a life-shortening autosomal recessive genetic disorder caused by mutation in the gene encoding the CF transmembrane conductance regulator (CFTR). Dysfunction in CFTR leads to the accumulation of thick and dehydrated mucus in the respiratory tract, which serves as a substrate for a complex microbiota that includes commensal oral and respiratory bacteria and opportunistic pathogenic bacteria and fungi. During chronic infections, these microbes persist in the airways and contribute to progressive lung tissue damage, ultimately leading to respiratory failure and premature death. Within this environment, microbes synthesize a diverse repertoire of natural products, including antimicrobials, siderophores and other metallophores, signaling molecules, toxins, and other virulence factors. In this review, we thoroughly discuss natural products produced by members of the CF airway microbiota, primarily the bacterial pathogens Burkholderia spp., Pseudomonas aeruginosa, and Staphylococcus aureus and the fungal pathogens Aspergillus fumigatus and Scedosporium spp. When known, we describe the biosynthesis and roles of these natural products in microbial persistence, interspecies interactions, and virulence in the CF airway. When these roles are unknown, we infer potential roles based on evidence from the literature in different disease contexts. Finally, we briefly highlight natural products produced by the CF microbiota as novel sources for developing new antimicrobials and as drug targets to treat disease.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about anti-D immunoglobulin